Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cytokine Sustained Delivery for Cancer Therapy; Special Focus on Stem Cell- and Biomaterial- Based Delivery Methods Publisher Pubmed



Mehralizadeh H1 ; Nazari A2 ; Oruji F3 ; Roostaie M4 ; Hosseininozari G5 ; Yazdani O6 ; Esbati R6 ; Roudini K7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  2. 2. Tehran University of Medical Sciences, Tehran, Iran
  3. 3. College of Medicine, Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, United States
  4. 4. School of Medicine, Islamic Azad University Tehran Medical Branch, Tehran, Iran
  5. 5. Department of Cell and Molecular biology, Babol Branch, Islamic Azad University, Babol, Iran
  6. 6. Department of Medicine, Shahid Beheshti University, Tehran, Iran
  7. 7. Department of Internal Medicine, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Iran

Source: Pathology Research and Practice Published:2023


Abstract

As immune regulators, cytokines serve critical role as signaling molecules in response to danger, tissue damage, or injury. Importantly, due to their vital role in immunological surveillance, cytokine therapy has become a promising therapeutics for cancer therapy. Cytokines have, however, been used only in certain clinical settings. Two key characteristics of cytokines contribute to this clinical translational challenge: first, they are highly pleiotropic, and second, in healthy physiology, they are typically secreted and act very locally in tissues. Systemic administration of the cytokines can consequently result in serious side effects. Thus, scientists have sought various strategies to circumvent theses hurdles. Recent in vivo reports signify that cytokine delivery platforms can increase their safety and therapeutic efficacy in tumor xenografts. Meanwhile, cytokine delivery using multipotent stem cells, in particular mesenchymal stem/stromal cells (MSCs), and also a diversity of particles and biomaterials has demonstrated greater capability in this regards. Herein, we take a glimpse into the recent advances in cytokine sustained delivery using stem cells and also biomaterials to ease safe and effective treatments of a myriad of human tumors. © 2023 Elsevier GmbH
Related Docs
View other Related Docs
1. Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy, Frontiers in Cell and Developmental Biology (2021)
2. Genetically Engineered Mesenchymal Stem Cells: Targeted Delivery of Immunomodulatory Agents for Tumor Eradication, Cancer Gene Therapy (2020)
3. Nanotechnology and Bioengineering Approaches to Improve the Potency of Mesenchymal Stem Cell As an Off-The-Shelf Versatile Tumor Delivery Vehicle, Medicinal Research Reviews (2024)
4. Recent Advancements to Engineer Mesenchymal Stem Cells and Their Extracellular Vesicles for Targeting and Destroying Tumors, Progress in Biophysics and Molecular Biology (2023)
5. Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents, Current Medicinal Chemistry (2016)
6. Mesenchymal Stem Cells As Professional Actors in Gastrointestinal Cancer Therapy: From Naive to Genetically Modified, Iranian Journal of Basic Medical Sciences (2021)
7. Therapeutic Application of Multipotent Stem Cells, Journal of Cellular Physiology (2018)
8. Genetically-Modified Stem Cell in Regenerative Medicine and Cancer Therapy; a New Era, Current Gene Therapy (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (7)
Hamid Reza Mirzaei (4)
Other Related Docs
9. Harnessing Trail-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges, Frontiers in Immunology (2021)
10. Emerging Role of Mesenchymal Stromal Cells (Mscs)-Derived Exosome in Neurodegeneration-Associated Conditions: A Groundbreaking Cell-Free Approach, Stem Cell Research and Therapy (2022)
11. Biological Aspects and Clinical Applications of Mesenchymal Stem Cells: Key Features You Need to Be Aware Of, Current Pharmaceutical Biotechnology (2021)
12. Stem Cells and Targeted Gene Therapy in Brain and Spinal Cord Tumors, Advances in Experimental Medicine and Biology (2023)
13. Detailed Role of Mesenchymal Stem Cell (Msc)-Derived Exosome Therapy in Cardiac Diseases, EXCLI Journal (2024)
14. Mesenchymal Stem Cell: A New Horizon in Cancer Gene Therapy, Cancer Gene Therapy (2016)
15. Promotion of Cell-Based Therapy: Special Focus on the Cooperation of Mesenchymal Stem Cell Therapy and Gene Therapy for Clinical Trial Studies, Advances in Experimental Medicine and Biology (2018)
16. The Therapeutic Values of Il-7/Il-7R and the Recombinant Derivatives in Glioma: A Narrative Review, Journal of Interferon and Cytokine Research (2023)
17. The Nlrp3 Inflammasome: A Therapeutic Target for Inflammation-Associated Cancers, Expert Review of Clinical Immunology (2020)
18. Genetically Engineered Mesenchymal Stromal Cells As a New Trend for Treatment of Severe Acute Graft-Versus-Host Disease, Clinical and Experimental Immunology (2022)
19. Bioengineering Strategies to Enhance the Interleukin-18 Bioactivity in the Modern Toolbox of Cancer Immunotherapy, Cytokine and Growth Factor Reviews (2024)
20. A Paradigm Shift in Cell-Free Approach: The Emerging Role of Mscs-Derived Exosomes in Regenerative Medicine, Journal of Translational Medicine (2021)
21. Mscs and Their Exosomes: A Rapidly Evolving Approach in the Context of Cutaneous Wounds Therapy, Stem Cell Research and Therapy (2021)
22. The Potential Use of Mesenchymal Stem Cells-Derived Exosomes As Micrornas Delivery Systems in Different Diseases, Cell Communication and Signaling (2023)
23. Nlrp3 Inflammasome: Significance and Potential Therapeutic Targets to Advance Solid Organ Transplantation, Expert Opinion on Therapeutic Targets (2025)
24. Emerging Role of Mesenchymal Stem/Stromal Cells (Mscs) and Mscs-Derived Exosomes in Bone- and Joint-Associated Musculoskeletal Disorders: A New Frontier, European Journal of Medical Research (2023)
25. Bypassing the Need for Pre-Sensitization of Cancer Cells for Anticancer Trail Therapy With Secretion of Novel Cell Penetrable Form of Smac From Ha-Mscs As Cellular Delivery Vehicle, Tumor Biology (2015)
26. Cell and Cell-Derivative-Based Therapy for Liver Diseases: Current Approaches and Future Promises, Expert Review of Gastroenterology and Hepatology (2023)
27. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
28. Mesenchymal Stromal Cells Induce Inhibitory Effects on Hepatocellular Carcinoma Through Various Signaling Pathways, Cancer Cell International (2019)
29. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
30. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
31. Mesenchymal Stem Cells (Mscs) and Msc-Derived Exosomes in Animal Models of Central Nervous System Diseases: Targeting the Nlrp3 Inflammasome, IUBMB Life (2023)
32. Il-2Rg As a Possible Immunotherapeutic Target in Crc Predicting Poor Prognosis and Regulated by Mir-7-5P and Mir-26B-5P, Journal of Translational Medicine (2024)
33. Clinical Potential of Pd-1/Pd-L1 Blockade Therapy for Renal Cell Carcinoma (Rcc): A Rapidly Evolving Strategy, Cancer Cell International (2022)
34. Natural Killer Cells and Acute Myeloid Leukemia: Promises and Challenges, Cancer Immunology# Immunotherapy (2022)
35. The Therapeutic Potential of Human Adipose-Derived Mesenchymal Stem Cells Producing Cxcl10 in a Mouse Melanoma Lung Metastasis Model, Cancer Letters (2018)